Document Type


Publication Date



Guatemala is a developing nation of nearly 16 million in Central America. Among the many health problems the nation suffers, cervical cancer remains a leading cause of cancer-related death. Cervical cancer, an easily detectable cancer, predominantly affects women in developing nations. Traditional cytology techniques have been used to screen women in the country for over 25 years, but less than 10% of the Guatemalan population is screened. The Visual Inspection with Acetic Acid (VIA) is a simple produce that uses acetic acid to visualize precancerous cervical lesions and has been proven to be more effective in resource-poor settings. The screening is less financially burdensome, requires basic supplies and fewer trained professionals, and can be performed and treated in one single visit. While Guatemala has implemented VIA screening in high-burden areas, it is critical that the nation expand screening programs so that more women have access to treatment.